2015-2027 Global Opioid-Induced Constipation Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
The worldwide market for Opioid-Induced Constipation is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.
Major Companies Covered
C.B. Fleet
Progenics Pharmaceuticals
Nektar Therapeutics
Merck
SLA Pharma
Johnson and Johnson
GlaxoSmithKline
Daewoong
Sucampo
Mundipharma
Abbott
Pfizer
Ironwood Pharmaceuticals
Cosmo Pharmaceuticals
Synergy Pharmaceuticals
Shionogi
AstraZeneca
Daiichi Sankyo
Bayer
Valeant Pharmaceuticals International
Boehringer Ingelheim
Takeda Pharmaceutical
Theravance
Major Types Covered
Oral
Parenteral
Major Applications Covered
Drugstore
Hospital
Others
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.
Major Companies Covered
C.B. Fleet
Progenics Pharmaceuticals
Nektar Therapeutics
Merck
SLA Pharma
Johnson and Johnson
GlaxoSmithKline
Daewoong
Sucampo
Mundipharma
Abbott
Pfizer
Ironwood Pharmaceuticals
Cosmo Pharmaceuticals
Synergy Pharmaceuticals
Shionogi
AstraZeneca
Daiichi Sankyo
Bayer
Valeant Pharmaceuticals International
Boehringer Ingelheim
Takeda Pharmaceutical
Theravance
Major Types Covered
Oral
Parenteral
Major Applications Covered
Drugstore
Hospital
Others
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 KEY FINDINGS OF THE STUDY
3 MARKET DYNAMICS
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Opioid-Induced Constipation Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Opioid-Induced Constipation Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 VALUE CHAIN OF THE OPIOID-INDUCED CONSTIPATION MARKET
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET-SEGMENTATION BY TYPE
5.1 Oral
5.2 Parenteral
6 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET-SEGMENTATION BY APPLICATION
6.1 Drugstore
6.2 Hospital
6.3 Others
7 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET-SEGMENTATION BY MARKETING CHANNEL
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES
8.1 C.B. Fleet
8.1.1 C.B. Fleet Profile
8.1.2 C.B. Fleet Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 C.B. Fleet Product/Solution Launches and Enhancements Analysis
8.1.4 C.B. Fleet Business Overview/Recent Development/Acquisitions
8.2 Progenics Pharmaceuticals
8.2.1 Progenics Pharmaceuticals Profile
8.2.2 Progenics Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Progenics Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.2.4 Progenics Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.3 Nektar Therapeutics
8.3.1 Nektar Therapeutics Profile
8.3.2 Nektar Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Nektar Therapeutics Product/Solution Launches and Enhancements Analysis
8.3.4 Nektar Therapeutics Business Overview/Recent Development/Acquisitions
8.4 Merck
8.4.1 Merck Profile
8.4.2 Merck Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Merck Product/Solution Launches and Enhancements Analysis
8.4.4 Merck Business Overview/Recent Development/Acquisitions
8.5 SLA Pharma
8.5.1 SLA Pharma Profile
8.5.2 SLA Pharma Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 SLA Pharma Product/Solution Launches and Enhancements Analysis
8.5.4 SLA Pharma Business Overview/Recent Development/Acquisitions
8.6 Johnson and Johnson
8.6.1 Johnson and Johnson Profile
8.6.2 Johnson and Johnson Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Johnson and Johnson Product/Solution Launches and Enhancements Analysis
8.6.4 Johnson and Johnson Business Overview/Recent Development/Acquisitions
8.7 GlaxoSmithKline
8.7.1 GlaxoSmithKline Profile
8.7.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis
8.7.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
8.8 Daewoong
8.8.1 Daewoong Profile
8.8.2 Daewoong Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Daewoong Product/Solution Launches and Enhancements Analysis
8.8.4 Daewoong Business Overview/Recent Development/Acquisitions
8.9 Sucampo
8.9.1 Sucampo Profile
8.9.2 Sucampo Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Sucampo Product/Solution Launches and Enhancements Analysis
8.9.4 Sucampo Business Overview/Recent Development/Acquisitions
8.10 Mundipharma
8.10.1 Mundipharma Profile
8.10.2 Mundipharma Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Mundipharma Product/Solution Launches and Enhancements Analysis
8.10.4 Mundipharma Business Overview/Recent Development/Acquisitions
8.11 Abbott
8.11.1 Abbott Profile
8.11.2 Abbott Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Abbott Product/Solution Launches and Enhancements Analysis
8.11.4 Abbott Business Overview/Recent Development/Acquisitions
8.12 Pfizer
8.12.1 Pfizer Profile
8.12.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.12.4 Pfizer Business Overview/Recent Development/Acquisitions
8.13 Ironwood Pharmaceuticals
8.13.1 Ironwood Pharmaceuticals Profile
8.13.2 Ironwood Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Ironwood Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.13.4 Ironwood Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.14 Cosmo Pharmaceuticals
8.14.1 Cosmo Pharmaceuticals Profile
8.14.2 Cosmo Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Cosmo Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.14.4 Cosmo Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.15 Synergy Pharmaceuticals
8.15.1 Synergy Pharmaceuticals Profile
8.15.2 Synergy Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 Synergy Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.15.4 Synergy Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.16 Shionogi
8.16.1 Shionogi Profile
8.16.2 Shionogi Sales, Growth Rate and Global Market Share from 2015-2020
8.16.3 Shionogi Product/Solution Launches and Enhancements Analysis
8.16.4 Shionogi Business Overview/Recent Development/Acquisitions
8.17 AstraZeneca
8.17.1 AstraZeneca Profile
8.17.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
8.17.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
8.17.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.18 Daiichi Sankyo
8.18.1 Daiichi Sankyo Profile
8.18.2 Daiichi Sankyo Sales, Growth Rate and Global Market Share from 2015-2020
8.18.3 Daiichi Sankyo Product/Solution Launches and Enhancements Analysis
8.18.4 Daiichi Sankyo Business Overview/Recent Development/Acquisitions
8.19 Bayer
8.19.1 Bayer Profile
8.19.2 Bayer Sales, Growth Rate and Global Market Share from 2015-2020
8.19.3 Bayer Product/Solution Launches and Enhancements Analysis
8.19.4 Bayer Business Overview/Recent Development/Acquisitions
8.20 Valeant Pharmaceuticals International
8.20.1 Valeant Pharmaceuticals International Profile
8.20.2 Valeant Pharmaceuticals International Sales, Growth Rate and Global Market Share from 2015-2020
8.20.3 Valeant Pharmaceuticals International Product/Solution Launches and Enhancements Analysis
8.20.4 Valeant Pharmaceuticals International Business Overview/Recent Development/Acquisitions
8.21 Boehringer Ingelheim
8.21.1 Boehringer Ingelheim Profile
8.21.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2015-2020
8.21.3 Boehringer Ingelheim Product/Solution Launches and Enhancements Analysis
8.21.4 Boehringer Ingelheim Business Overview/Recent Development/Acquisitions
8.22 Takeda Pharmaceutical
8.22.1 Takeda Pharmaceutical Profile
8.22.2 Takeda Pharmaceutical Sales, Growth Rate and Global Market Share from 2015-2020
8.22.3 Takeda Pharmaceutical Product/Solution Launches and Enhancements Analysis
8.22.4 Takeda Pharmaceutical Business Overview/Recent Development/Acquisitions
8.23 Theravance
8.23.1 Theravance Profile
8.23.2 Theravance Sales, Growth Rate and Global Market Share from 2015-2020
8.23.3 Theravance Product/Solution Launches and Enhancements Analysis
8.23.4 Theravance Business Overview/Recent Development/Acquisitions
9 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET-SEGMENTATION BY GEOGRAPHY
10 NORTH AMERICA
10.1 North America Opioid-Induced Constipation Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Opioid-Induced Constipation Production Analysis from 2015-2020
10.4 North America Opioid-Induced Constipation Consumption Analysis from 2015-2020
10.5 North America Opioid-Induced Constipation Import and Export from 2015-2020
10.6 North America Opioid-Induced Constipation Value, Production and Market Share by Type (2015-2020)
10.7 North America Opioid-Induced Constipation Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Opioid-Induced Constipation by Country (United States, Canada)
10.8.1 North America Opioid-Induced Constipation Sales by Country (2015-2020)
10.8.2 North America Opioid-Induced Constipation Consumption Value by Country (2015-2020)
10.9 North America Opioid-Induced Constipation Market PEST Analysis
11 EUROPE
11.1 Europe Opioid-Induced Constipation Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Opioid-Induced Constipation Production Analysis from 2015-2020
11.4 Europe Opioid-Induced Constipation Consumption Analysis from 2015-2020
11.5 Europe Opioid-Induced Constipation Import and Export from 2015-2020
11.6 Europe Opioid-Induced Constipation Value, Production and Market Share by Type (2015-2020)
11.7 Europe Opioid-Induced Constipation Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Opioid-Induced Constipation by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Opioid-Induced Constipation Sales by Country (2015-2020)
11.8.2 Europe Opioid-Induced Constipation Consumption Value by Country (2015-2020)
11.9 Europe Opioid-Induced Constipation Market PEST Analysis
12 ASIA-PACIFIC
12.1 Asia-Pacific Opioid-Induced Constipation Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Opioid-Induced Constipation Production Analysis from 2015-2020
12.4 Asia-Pacific Opioid-Induced Constipation Consumption Analysis from 2015-2020
12.5 Asia-Pacific Opioid-Induced Constipation Import and Export from 2015-2020
12.6 Asia-Pacific Opioid-Induced Constipation Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Opioid-Induced Constipation Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Opioid-Induced Constipation by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Opioid-Induced Constipation Sales by Country (2015-2020)
12.8.2 Asia-Pacific Opioid-Induced Constipation Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Opioid-Induced Constipation Market PEST Analysis
13 LATIN AMERICA
13.1 Latin America Opioid-Induced Constipation Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Opioid-Induced Constipation Production Analysis from 2015-2020
13.4 Latin America Opioid-Induced Constipation Consumption Analysis from 2015-2020
13.5 Latin America Opioid-Induced Constipation Import and Export from 2015-2020
13.6 Latin America Opioid-Induced Constipation Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Opioid-Induced Constipation Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Opioid-Induced Constipation by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Opioid-Induced Constipation Sales by Country (2015-2020)
13.8.2 Latin America Opioid-Induced Constipation Consumption Value by Country (2015-2020)
13.9 Latin America Opioid-Induced Constipation Market PEST Analysis
14 MIDDLE EAST & AFRICA
14.1 Middle East & Africa Opioid-Induced Constipation Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Opioid-Induced Constipation Production Analysis from 2015-2020
14.4 Middle East & Africa Opioid-Induced Constipation Consumption Analysis from 2015-2020
14.5 Middle East & Africa Opioid-Induced Constipation Import and Export from 2015-2020
14.6 Middle East & Africa Opioid-Induced Constipation Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Opioid-Induced Constipation Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Opioid-Induced Constipation by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Opioid-Induced Constipation Sales by Country (2015-2020)
14.8.2 Middle East & Africa Opioid-Induced Constipation Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Opioid-Induced Constipation Market PEST Analysis
15 FUTURE FORECAST OF THE GLOBAL OPIOID-INDUCED CONSTIPATION MARKET FROM 2020-2027
15.1 Future Forecast of the Global Opioid-Induced Constipation Market from 2020-2027 Segment by Region
15.2 Global Opioid-Induced Constipation Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Opioid-Induced Constipation Consumption and Growth Rate Forecast by Application (2020-2027)
16 APPENDIX
16.1 Methodology
16.2 Research Data Source
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 KEY FINDINGS OF THE STUDY
3 MARKET DYNAMICS
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Opioid-Induced Constipation Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Opioid-Induced Constipation Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 VALUE CHAIN OF THE OPIOID-INDUCED CONSTIPATION MARKET
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET-SEGMENTATION BY TYPE
5.1 Oral
5.2 Parenteral
6 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET-SEGMENTATION BY APPLICATION
6.1 Drugstore
6.2 Hospital
6.3 Others
7 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET-SEGMENTATION BY MARKETING CHANNEL
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES
8.1 C.B. Fleet
8.1.1 C.B. Fleet Profile
8.1.2 C.B. Fleet Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 C.B. Fleet Product/Solution Launches and Enhancements Analysis
8.1.4 C.B. Fleet Business Overview/Recent Development/Acquisitions
8.2 Progenics Pharmaceuticals
8.2.1 Progenics Pharmaceuticals Profile
8.2.2 Progenics Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Progenics Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.2.4 Progenics Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.3 Nektar Therapeutics
8.3.1 Nektar Therapeutics Profile
8.3.2 Nektar Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Nektar Therapeutics Product/Solution Launches and Enhancements Analysis
8.3.4 Nektar Therapeutics Business Overview/Recent Development/Acquisitions
8.4 Merck
8.4.1 Merck Profile
8.4.2 Merck Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Merck Product/Solution Launches and Enhancements Analysis
8.4.4 Merck Business Overview/Recent Development/Acquisitions
8.5 SLA Pharma
8.5.1 SLA Pharma Profile
8.5.2 SLA Pharma Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 SLA Pharma Product/Solution Launches and Enhancements Analysis
8.5.4 SLA Pharma Business Overview/Recent Development/Acquisitions
8.6 Johnson and Johnson
8.6.1 Johnson and Johnson Profile
8.6.2 Johnson and Johnson Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Johnson and Johnson Product/Solution Launches and Enhancements Analysis
8.6.4 Johnson and Johnson Business Overview/Recent Development/Acquisitions
8.7 GlaxoSmithKline
8.7.1 GlaxoSmithKline Profile
8.7.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis
8.7.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
8.8 Daewoong
8.8.1 Daewoong Profile
8.8.2 Daewoong Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Daewoong Product/Solution Launches and Enhancements Analysis
8.8.4 Daewoong Business Overview/Recent Development/Acquisitions
8.9 Sucampo
8.9.1 Sucampo Profile
8.9.2 Sucampo Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Sucampo Product/Solution Launches and Enhancements Analysis
8.9.4 Sucampo Business Overview/Recent Development/Acquisitions
8.10 Mundipharma
8.10.1 Mundipharma Profile
8.10.2 Mundipharma Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Mundipharma Product/Solution Launches and Enhancements Analysis
8.10.4 Mundipharma Business Overview/Recent Development/Acquisitions
8.11 Abbott
8.11.1 Abbott Profile
8.11.2 Abbott Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Abbott Product/Solution Launches and Enhancements Analysis
8.11.4 Abbott Business Overview/Recent Development/Acquisitions
8.12 Pfizer
8.12.1 Pfizer Profile
8.12.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.12.4 Pfizer Business Overview/Recent Development/Acquisitions
8.13 Ironwood Pharmaceuticals
8.13.1 Ironwood Pharmaceuticals Profile
8.13.2 Ironwood Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Ironwood Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.13.4 Ironwood Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.14 Cosmo Pharmaceuticals
8.14.1 Cosmo Pharmaceuticals Profile
8.14.2 Cosmo Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Cosmo Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.14.4 Cosmo Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.15 Synergy Pharmaceuticals
8.15.1 Synergy Pharmaceuticals Profile
8.15.2 Synergy Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 Synergy Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.15.4 Synergy Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.16 Shionogi
8.16.1 Shionogi Profile
8.16.2 Shionogi Sales, Growth Rate and Global Market Share from 2015-2020
8.16.3 Shionogi Product/Solution Launches and Enhancements Analysis
8.16.4 Shionogi Business Overview/Recent Development/Acquisitions
8.17 AstraZeneca
8.17.1 AstraZeneca Profile
8.17.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
8.17.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
8.17.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.18 Daiichi Sankyo
8.18.1 Daiichi Sankyo Profile
8.18.2 Daiichi Sankyo Sales, Growth Rate and Global Market Share from 2015-2020
8.18.3 Daiichi Sankyo Product/Solution Launches and Enhancements Analysis
8.18.4 Daiichi Sankyo Business Overview/Recent Development/Acquisitions
8.19 Bayer
8.19.1 Bayer Profile
8.19.2 Bayer Sales, Growth Rate and Global Market Share from 2015-2020
8.19.3 Bayer Product/Solution Launches and Enhancements Analysis
8.19.4 Bayer Business Overview/Recent Development/Acquisitions
8.20 Valeant Pharmaceuticals International
8.20.1 Valeant Pharmaceuticals International Profile
8.20.2 Valeant Pharmaceuticals International Sales, Growth Rate and Global Market Share from 2015-2020
8.20.3 Valeant Pharmaceuticals International Product/Solution Launches and Enhancements Analysis
8.20.4 Valeant Pharmaceuticals International Business Overview/Recent Development/Acquisitions
8.21 Boehringer Ingelheim
8.21.1 Boehringer Ingelheim Profile
8.21.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2015-2020
8.21.3 Boehringer Ingelheim Product/Solution Launches and Enhancements Analysis
8.21.4 Boehringer Ingelheim Business Overview/Recent Development/Acquisitions
8.22 Takeda Pharmaceutical
8.22.1 Takeda Pharmaceutical Profile
8.22.2 Takeda Pharmaceutical Sales, Growth Rate and Global Market Share from 2015-2020
8.22.3 Takeda Pharmaceutical Product/Solution Launches and Enhancements Analysis
8.22.4 Takeda Pharmaceutical Business Overview/Recent Development/Acquisitions
8.23 Theravance
8.23.1 Theravance Profile
8.23.2 Theravance Sales, Growth Rate and Global Market Share from 2015-2020
8.23.3 Theravance Product/Solution Launches and Enhancements Analysis
8.23.4 Theravance Business Overview/Recent Development/Acquisitions
9 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET-SEGMENTATION BY GEOGRAPHY
10 NORTH AMERICA
10.1 North America Opioid-Induced Constipation Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Opioid-Induced Constipation Production Analysis from 2015-2020
10.4 North America Opioid-Induced Constipation Consumption Analysis from 2015-2020
10.5 North America Opioid-Induced Constipation Import and Export from 2015-2020
10.6 North America Opioid-Induced Constipation Value, Production and Market Share by Type (2015-2020)
10.7 North America Opioid-Induced Constipation Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Opioid-Induced Constipation by Country (United States, Canada)
10.8.1 North America Opioid-Induced Constipation Sales by Country (2015-2020)
10.8.2 North America Opioid-Induced Constipation Consumption Value by Country (2015-2020)
10.9 North America Opioid-Induced Constipation Market PEST Analysis
11 EUROPE
11.1 Europe Opioid-Induced Constipation Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Opioid-Induced Constipation Production Analysis from 2015-2020
11.4 Europe Opioid-Induced Constipation Consumption Analysis from 2015-2020
11.5 Europe Opioid-Induced Constipation Import and Export from 2015-2020
11.6 Europe Opioid-Induced Constipation Value, Production and Market Share by Type (2015-2020)
11.7 Europe Opioid-Induced Constipation Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Opioid-Induced Constipation by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Opioid-Induced Constipation Sales by Country (2015-2020)
11.8.2 Europe Opioid-Induced Constipation Consumption Value by Country (2015-2020)
11.9 Europe Opioid-Induced Constipation Market PEST Analysis
12 ASIA-PACIFIC
12.1 Asia-Pacific Opioid-Induced Constipation Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Opioid-Induced Constipation Production Analysis from 2015-2020
12.4 Asia-Pacific Opioid-Induced Constipation Consumption Analysis from 2015-2020
12.5 Asia-Pacific Opioid-Induced Constipation Import and Export from 2015-2020
12.6 Asia-Pacific Opioid-Induced Constipation Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Opioid-Induced Constipation Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Opioid-Induced Constipation by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Opioid-Induced Constipation Sales by Country (2015-2020)
12.8.2 Asia-Pacific Opioid-Induced Constipation Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Opioid-Induced Constipation Market PEST Analysis
13 LATIN AMERICA
13.1 Latin America Opioid-Induced Constipation Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Opioid-Induced Constipation Production Analysis from 2015-2020
13.4 Latin America Opioid-Induced Constipation Consumption Analysis from 2015-2020
13.5 Latin America Opioid-Induced Constipation Import and Export from 2015-2020
13.6 Latin America Opioid-Induced Constipation Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Opioid-Induced Constipation Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Opioid-Induced Constipation by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Opioid-Induced Constipation Sales by Country (2015-2020)
13.8.2 Latin America Opioid-Induced Constipation Consumption Value by Country (2015-2020)
13.9 Latin America Opioid-Induced Constipation Market PEST Analysis
14 MIDDLE EAST & AFRICA
14.1 Middle East & Africa Opioid-Induced Constipation Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Opioid-Induced Constipation Production Analysis from 2015-2020
14.4 Middle East & Africa Opioid-Induced Constipation Consumption Analysis from 2015-2020
14.5 Middle East & Africa Opioid-Induced Constipation Import and Export from 2015-2020
14.6 Middle East & Africa Opioid-Induced Constipation Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Opioid-Induced Constipation Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Opioid-Induced Constipation by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Opioid-Induced Constipation Sales by Country (2015-2020)
14.8.2 Middle East & Africa Opioid-Induced Constipation Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Opioid-Induced Constipation Market PEST Analysis
15 FUTURE FORECAST OF THE GLOBAL OPIOID-INDUCED CONSTIPATION MARKET FROM 2020-2027
15.1 Future Forecast of the Global Opioid-Induced Constipation Market from 2020-2027 Segment by Region
15.2 Global Opioid-Induced Constipation Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Opioid-Induced Constipation Consumption and Growth Rate Forecast by Application (2020-2027)
16 APPENDIX
16.1 Methodology
16.2 Research Data Source
LIST OF TABLES AND FIGURES
Global Opioid-Induced Constipation Market Value ($) and Growth Rate of Opioid-Induced Constipation from 2015-2027
Global Opioid-Induced Constipation Production and Growth Rate Segment by Product Type from 2015-2027
Global Opioid-Induced Constipation Consumption and Growth Rate Segment by Application from 2015-2027
Figure Opioid-Induced Constipation Picture
Table Product Specifications of Opioid-Induced Constipation
Table Driving Factors for this Market
Table Industry News of Opioid-Induced Constipation Market
Figure Value Chain Status of Opioid-Induced Constipation
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Opioid-Induced Constipation Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Opioid-Induced Constipation Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Oral of Opioid-Induced Constipation
Figure Parenteral of Opioid-Induced Constipation
Table Global Opioid-Induced Constipation Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Opioid-Induced Constipation Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Drugstore of Opioid-Induced Constipation
Figure Hospital of Opioid-Induced Constipation
Figure Others of Opioid-Induced Constipation
Table Global Opioid-Induced Constipation Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Opioid-Induced Constipation Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Opioid-Induced Constipation
Figure Online Channel of Opioid-Induced Constipation
Table C.B. Fleet Profile (Company Name, Plants Distribution, Sales Region)
Figure C.B. Fleet Sales and Growth Rate from 2015-2020
Figure C.B. Fleet Revenue ($) and Global Market Share from 2015-2020
Table C.B. Fleet Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Progenics Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Progenics Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Progenics Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Nektar Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Nektar Therapeutics Sales and Growth Rate from 2015-2020
Figure Nektar Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Nektar Therapeutics Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck Sales and Growth Rate from 2015-2020
Figure Merck Revenue ($) and Global Market Share from 2015-2020
Table Merck Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table SLA Pharma Profile (Company Name, Plants Distribution, Sales Region)
Figure SLA Pharma Sales and Growth Rate from 2015-2020
Figure SLA Pharma Revenue ($) and Global Market Share from 2015-2020
Table SLA Pharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson and Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson and Johnson Sales and Growth Rate from 2015-2020
Figure Johnson and Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson and Johnson Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table GlaxoSmithKline Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline Sales and Growth Rate from 2015-2020
Figure GlaxoSmithKline Revenue ($) and Global Market Share from 2015-2020
Table GlaxoSmithKline Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Daewoong Profile (Company Name, Plants Distribution, Sales Region)
Figure Daewoong Sales and Growth Rate from 2015-2020
Figure Daewoong Revenue ($) and Global Market Share from 2015-2020
Table Daewoong Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sucampo Profile (Company Name, Plants Distribution, Sales Region)
Figure Sucampo Sales and Growth Rate from 2015-2020
Figure Sucampo Revenue ($) and Global Market Share from 2015-2020
Table Sucampo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Mundipharma Profile (Company Name, Plants Distribution, Sales Region)
Figure Mundipharma Sales and Growth Rate from 2015-2020
Figure Mundipharma Revenue ($) and Global Market Share from 2015-2020
Table Mundipharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Abbott Profile (Company Name, Plants Distribution, Sales Region)
Figure Abbott Sales and Growth Rate from 2015-2020
Figure Abbott Revenue ($) and Global Market Share from 2015-2020
Table Abbott Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ironwood Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Ironwood Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Ironwood Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Ironwood Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Cosmo Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Cosmo Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Cosmo Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Cosmo Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Synergy Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Synergy Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Synergy Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Synergy Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Shionogi Profile (Company Name, Plants Distribution, Sales Region)
Figure Shionogi Sales and Growth Rate from 2015-2020
Figure Shionogi Revenue ($) and Global Market Share from 2015-2020
Table Shionogi Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table AstraZeneca Profile (Company Name, Plants Distribution, Sales Region)
Figure AstraZeneca Sales and Growth Rate from 2015-2020
Figure AstraZeneca Revenue ($) and Global Market Share from 2015-2020
Table AstraZeneca Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Daiichi Sankyo Profile (Company Name, Plants Distribution, Sales Region)
Figure Daiichi Sankyo Sales and Growth Rate from 2015-2020
Figure Daiichi Sankyo Revenue ($) and Global Market Share from 2015-2020
Table Daiichi Sankyo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bayer Profile (Company Name, Plants Distribution, Sales Region)
Figure Bayer Sales and Growth Rate from 2015-2020
Figure Bayer Revenue ($) and Global Market Share from 2015-2020
Table Bayer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Valeant Pharmaceuticals International Profile (Company Name, Plants Distribution, Sales Region)
Figure Valeant Pharmaceuticals International Sales and Growth Rate from 2015-2020
Figure Valeant Pharmaceuticals International Revenue ($) and Global Market Share from 2015-2020
Table Valeant Pharmaceuticals International Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Boehringer Ingelheim Profile (Company Name, Plants Distribution, Sales Region)
Figure Boehringer Ingelheim Sales and Growth Rate from 2015-2020
Figure Boehringer Ingelheim Revenue ($) and Global Market Share from 2015-2020
Table Boehringer Ingelheim Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Takeda Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region)
Figure Takeda Pharmaceutical Sales and Growth Rate from 2015-2020
Figure Takeda Pharmaceutical Revenue ($) and Global Market Share from 2015-2020
Table Takeda Pharmaceutical Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Theravance Profile (Company Name, Plants Distribution, Sales Region)
Figure Theravance Sales and Growth Rate from 2015-2020
Figure Theravance Revenue ($) and Global Market Share from 2015-2020
Table Theravance Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Opioid-Induced Constipation Production Value ($) by Region from 2015-2020
Table Global Opioid-Induced Constipation Production Value Share by Region from 2015-2020
Table Global Opioid-Induced Constipation Production by Region from 2015-2020
Table Global Opioid-Induced Constipation Consumption Value ($) by Region from 2015-2020
Table Global Opioid-Induced Constipation Consumption by Region from 2015-2020
Table North America Opioid-Induced Constipation Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Opioid-Induced Constipation Import and Export from 2015-2020
Table North America Opioid-Induced Constipation Value ($) by Type (2015-2020)
Table North America Opioid-Induced Constipation Production by Type (2015-2020)
Table North America Opioid-Induced Constipation Consumption by Application (2015-2020)
Table North America Opioid-Induced Constipation Consumption by Country (2015-2020)
Table North America Opioid-Induced Constipation Consumption Value ($) by Country (2015-2020)
Figure North America Opioid-Induced Constipation Market PEST Analysis
Table Europe Opioid-Induced Constipation Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Opioid-Induced Constipation Import and Export from 2015-2020
Table Europe Opioid-Induced Constipation Value ($) by Type (2015-2020)
Table Europe Opioid-Induced Constipation Production by Type (2015-2020)
Table Europe Opioid-Induced Constipation Consumption by Application (2015-2020)
Table Europe Opioid-Induced Constipation Consumption by Country (2015-2020)
Table Europe Opioid-Induced Constipation Consumption Value ($) by Country (2015-2020)
Figure Europe Opioid-Induced Constipation Market PEST Analysis
Table Asia-Pacific Opioid-Induced Constipation Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Opioid-Induced Constipation Import and Export from 2015-2020
Table Asia-Pacific Opioid-Induced Constipation Value ($) by Type (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Production by Type (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Consumption by Application (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Consumption by Country (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Opioid-Induced Constipation Market PEST Analysis
Table Latin America Opioid-Induced Constipation Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Opioid-Induced Constipation Import and Export from 2015-2020
Table Latin America Opioid-Induced Constipation Value ($) by Type (2015-2020)
Table Latin America Opioid-Induced Constipation Production by Type (2015-2020)
Table Latin America Opioid-Induced Constipation Consumption by Application (2015-2020)
Table Latin America Opioid-Induced Constipation Consumption by Country (2015-2020)
Table Latin America Opioid-Induced Constipation Consumption Value ($) by Country (2015-2020)
Figure Latin America Opioid-Induced Constipation Market PEST Analysis
Table Middle East & Africa Opioid-Induced Constipation Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Opioid-Induced Constipation Import and Export from 2015-2020
Table Middle East & Africa Opioid-Induced Constipation Value ($) by Type (2015-2020)
Table Middle East & Africa Opioid-Induced Constipation Production by Type (2015-2020)
Table Middle East & Africa Opioid-Induced Constipation Consumption by Application (2015-2020)
Table Middle East & Africa Opioid-Induced Constipation Consumption by Country (2015-2020)
Table Middle East & Africa Opioid-Induced Constipation Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Opioid-Induced Constipation Market PEST Analysis
Table Global Opioid-Induced Constipation Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Opioid-Induced Constipation Production and Growth Rate Forecast by Region (2020-2027)
Table Global Opioid-Induced Constipation Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Opioid-Induced Constipation Production and Growth Rate Forecast by Type (2020-2027)
Table Global Opioid-Induced Constipation Consumption and Growth Rate Forecast by Application (2020-2027)
Global Opioid-Induced Constipation Market Value ($) and Growth Rate of Opioid-Induced Constipation from 2015-2027
Global Opioid-Induced Constipation Production and Growth Rate Segment by Product Type from 2015-2027
Global Opioid-Induced Constipation Consumption and Growth Rate Segment by Application from 2015-2027
Figure Opioid-Induced Constipation Picture
Table Product Specifications of Opioid-Induced Constipation
Table Driving Factors for this Market
Table Industry News of Opioid-Induced Constipation Market
Figure Value Chain Status of Opioid-Induced Constipation
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Opioid-Induced Constipation Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Opioid-Induced Constipation Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Oral of Opioid-Induced Constipation
Figure Parenteral of Opioid-Induced Constipation
Table Global Opioid-Induced Constipation Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Opioid-Induced Constipation Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Drugstore of Opioid-Induced Constipation
Figure Hospital of Opioid-Induced Constipation
Figure Others of Opioid-Induced Constipation
Table Global Opioid-Induced Constipation Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Opioid-Induced Constipation Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Opioid-Induced Constipation
Figure Online Channel of Opioid-Induced Constipation
Table C.B. Fleet Profile (Company Name, Plants Distribution, Sales Region)
Figure C.B. Fleet Sales and Growth Rate from 2015-2020
Figure C.B. Fleet Revenue ($) and Global Market Share from 2015-2020
Table C.B. Fleet Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Progenics Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Progenics Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Progenics Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Nektar Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Nektar Therapeutics Sales and Growth Rate from 2015-2020
Figure Nektar Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Nektar Therapeutics Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck Sales and Growth Rate from 2015-2020
Figure Merck Revenue ($) and Global Market Share from 2015-2020
Table Merck Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table SLA Pharma Profile (Company Name, Plants Distribution, Sales Region)
Figure SLA Pharma Sales and Growth Rate from 2015-2020
Figure SLA Pharma Revenue ($) and Global Market Share from 2015-2020
Table SLA Pharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson and Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson and Johnson Sales and Growth Rate from 2015-2020
Figure Johnson and Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson and Johnson Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table GlaxoSmithKline Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline Sales and Growth Rate from 2015-2020
Figure GlaxoSmithKline Revenue ($) and Global Market Share from 2015-2020
Table GlaxoSmithKline Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Daewoong Profile (Company Name, Plants Distribution, Sales Region)
Figure Daewoong Sales and Growth Rate from 2015-2020
Figure Daewoong Revenue ($) and Global Market Share from 2015-2020
Table Daewoong Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sucampo Profile (Company Name, Plants Distribution, Sales Region)
Figure Sucampo Sales and Growth Rate from 2015-2020
Figure Sucampo Revenue ($) and Global Market Share from 2015-2020
Table Sucampo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Mundipharma Profile (Company Name, Plants Distribution, Sales Region)
Figure Mundipharma Sales and Growth Rate from 2015-2020
Figure Mundipharma Revenue ($) and Global Market Share from 2015-2020
Table Mundipharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Abbott Profile (Company Name, Plants Distribution, Sales Region)
Figure Abbott Sales and Growth Rate from 2015-2020
Figure Abbott Revenue ($) and Global Market Share from 2015-2020
Table Abbott Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ironwood Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Ironwood Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Ironwood Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Ironwood Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Cosmo Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Cosmo Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Cosmo Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Cosmo Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Synergy Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Synergy Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Synergy Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Synergy Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Shionogi Profile (Company Name, Plants Distribution, Sales Region)
Figure Shionogi Sales and Growth Rate from 2015-2020
Figure Shionogi Revenue ($) and Global Market Share from 2015-2020
Table Shionogi Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table AstraZeneca Profile (Company Name, Plants Distribution, Sales Region)
Figure AstraZeneca Sales and Growth Rate from 2015-2020
Figure AstraZeneca Revenue ($) and Global Market Share from 2015-2020
Table AstraZeneca Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Daiichi Sankyo Profile (Company Name, Plants Distribution, Sales Region)
Figure Daiichi Sankyo Sales and Growth Rate from 2015-2020
Figure Daiichi Sankyo Revenue ($) and Global Market Share from 2015-2020
Table Daiichi Sankyo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bayer Profile (Company Name, Plants Distribution, Sales Region)
Figure Bayer Sales and Growth Rate from 2015-2020
Figure Bayer Revenue ($) and Global Market Share from 2015-2020
Table Bayer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Valeant Pharmaceuticals International Profile (Company Name, Plants Distribution, Sales Region)
Figure Valeant Pharmaceuticals International Sales and Growth Rate from 2015-2020
Figure Valeant Pharmaceuticals International Revenue ($) and Global Market Share from 2015-2020
Table Valeant Pharmaceuticals International Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Boehringer Ingelheim Profile (Company Name, Plants Distribution, Sales Region)
Figure Boehringer Ingelheim Sales and Growth Rate from 2015-2020
Figure Boehringer Ingelheim Revenue ($) and Global Market Share from 2015-2020
Table Boehringer Ingelheim Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Takeda Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region)
Figure Takeda Pharmaceutical Sales and Growth Rate from 2015-2020
Figure Takeda Pharmaceutical Revenue ($) and Global Market Share from 2015-2020
Table Takeda Pharmaceutical Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Theravance Profile (Company Name, Plants Distribution, Sales Region)
Figure Theravance Sales and Growth Rate from 2015-2020
Figure Theravance Revenue ($) and Global Market Share from 2015-2020
Table Theravance Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Opioid-Induced Constipation Production Value ($) by Region from 2015-2020
Table Global Opioid-Induced Constipation Production Value Share by Region from 2015-2020
Table Global Opioid-Induced Constipation Production by Region from 2015-2020
Table Global Opioid-Induced Constipation Consumption Value ($) by Region from 2015-2020
Table Global Opioid-Induced Constipation Consumption by Region from 2015-2020
Table North America Opioid-Induced Constipation Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Opioid-Induced Constipation Import and Export from 2015-2020
Table North America Opioid-Induced Constipation Value ($) by Type (2015-2020)
Table North America Opioid-Induced Constipation Production by Type (2015-2020)
Table North America Opioid-Induced Constipation Consumption by Application (2015-2020)
Table North America Opioid-Induced Constipation Consumption by Country (2015-2020)
Table North America Opioid-Induced Constipation Consumption Value ($) by Country (2015-2020)
Figure North America Opioid-Induced Constipation Market PEST Analysis
Table Europe Opioid-Induced Constipation Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Opioid-Induced Constipation Import and Export from 2015-2020
Table Europe Opioid-Induced Constipation Value ($) by Type (2015-2020)
Table Europe Opioid-Induced Constipation Production by Type (2015-2020)
Table Europe Opioid-Induced Constipation Consumption by Application (2015-2020)
Table Europe Opioid-Induced Constipation Consumption by Country (2015-2020)
Table Europe Opioid-Induced Constipation Consumption Value ($) by Country (2015-2020)
Figure Europe Opioid-Induced Constipation Market PEST Analysis
Table Asia-Pacific Opioid-Induced Constipation Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Opioid-Induced Constipation Import and Export from 2015-2020
Table Asia-Pacific Opioid-Induced Constipation Value ($) by Type (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Production by Type (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Consumption by Application (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Consumption by Country (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Opioid-Induced Constipation Market PEST Analysis
Table Latin America Opioid-Induced Constipation Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Opioid-Induced Constipation Import and Export from 2015-2020
Table Latin America Opioid-Induced Constipation Value ($) by Type (2015-2020)
Table Latin America Opioid-Induced Constipation Production by Type (2015-2020)
Table Latin America Opioid-Induced Constipation Consumption by Application (2015-2020)
Table Latin America Opioid-Induced Constipation Consumption by Country (2015-2020)
Table Latin America Opioid-Induced Constipation Consumption Value ($) by Country (2015-2020)
Figure Latin America Opioid-Induced Constipation Market PEST Analysis
Table Middle East & Africa Opioid-Induced Constipation Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Opioid-Induced Constipation Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Opioid-Induced Constipation Import and Export from 2015-2020
Table Middle East & Africa Opioid-Induced Constipation Value ($) by Type (2015-2020)
Table Middle East & Africa Opioid-Induced Constipation Production by Type (2015-2020)
Table Middle East & Africa Opioid-Induced Constipation Consumption by Application (2015-2020)
Table Middle East & Africa Opioid-Induced Constipation Consumption by Country (2015-2020)
Table Middle East & Africa Opioid-Induced Constipation Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Opioid-Induced Constipation Market PEST Analysis
Table Global Opioid-Induced Constipation Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Opioid-Induced Constipation Production and Growth Rate Forecast by Region (2020-2027)
Table Global Opioid-Induced Constipation Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Opioid-Induced Constipation Production and Growth Rate Forecast by Type (2020-2027)
Table Global Opioid-Induced Constipation Consumption and Growth Rate Forecast by Application (2020-2027)
